TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject inventio...

Full description

Saved in:
Bibliographic Details
Main Authors TARCIC NORA, BAR-ZOHAR DAN, KOFLER DINA
Format Patent
LanguageEnglish
Published 24.03.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first